Know Cancer

or
forgot password

Assessment of the Impact of Preoperative Stress Reduction on Psychological, Physiological and Immunological Parameters in Women With Gynecological Malignancies - Prospective Randomized Controlled Trial


Phase 3
18 Years
70 Years
Open (Enrolling)
Female
Cancer of Cervix, Ovarian Cancer, Cancer of Endometrium

Thank you

Trial Information

Assessment of the Impact of Preoperative Stress Reduction on Psychological, Physiological and Immunological Parameters in Women With Gynecological Malignancies - Prospective Randomized Controlled Trial


Surgery is considered one of the most stressful events in human life. Research indicates
that patients show high levels of stress from at least six days before surgery and up to a
week post the operation. Stress levels return to normalcy only after several weeks. Research
shows that psychological interventions given to women suffering from cancer can improve
their coping abilities and overall function, decreases stress levels, enhances adherence to
treatments,and increases quality of life and even life expectancy.

Women enrolled in this study will be divided into two groups: an experimental group and a
control group. Both groups will receive standard care. The control group will interact with
a nurse for one hour. The experimental group will receive one of two forms of psychological
intervention: either a cognitive intervention, or a psychophysiological intervention
(tailored to each woman).

Measurements and Instruments include: 1) Self-report questionnaires, such as:Profile of Mood
States (POMS-SF),Coping Inventory (COPE), Life Orientation Test Revised (LOT- R),Stress
Level Report, 2) Demographics, 3) Global assessment by the head nurse. 4)Physiological and
behavioral measures, such as: vital signs and use of medicine. 5)Hormonal and immunological
measures: levels of cortisol in saliva and plasma, levels of catecholamines in plasma,
salivary levels of IgA1, and peripheral blood NK cells and lymphocyte phenotyping.6)levels
of cytokines including IL-1,2,4,6,10,12, TNF-alpha, Interferon-gamma.

Time intervals for the collection of blood and saliva and the administration of the
questionnaires:

During the first week after being given the diagnosis and prior to the intervention:Blood &
saliva, Stress Level Report, POMS-SF, COPE, LOT-R

A day prior to surgery:Blood & saliva, Stress Level Report

On discharge from hospital:Blood & saliva, Stress Level Report

30 days after surgery:Stress Level Report,POMS-SF,COPE,LOT-R.


Inclusion Criteria:



- Woman with ovarian, cervical or endometrial cancer/tumor

- Women who speak Hebrew

- Women who sign the consent form

Exclusion Criteria:

- Women who have received neoadjuvant treatment

- Women suffering from any form of depression, anxiety or schizophrenia

- Women suffering from autoimmune or infectious diseases

- Women taking medications which have immunological effects (steroids ,beta-blockers)

- Women suffering from dementia or concentration problems

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

psychological, physiological, immunological parameters

Outcome Time Frame:

A week before surgery, the day befor surgery, day of hospital discharge, one month after surgery

Safety Issue:

No

Principal Investigator

Opher Caspi, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Director, Integrative Medicine - Rabin Medical Center

Authority:

Israel: Ethics Commission

Study ID:

0014-08-RMC

NCT ID:

NCT00726635

Start Date:

August 2008

Completion Date:

August 2009

Related Keywords:

  • Cancer of Cervix
  • Ovarian Cancer
  • Cancer of Endometrium
  • Endometrial Neoplasms
  • Sarcoma, Endometrial Stromal
  • Uterine Cervical Neoplasms
  • Ovarian Neoplasms

Name

Location